NCT05276024

Brief Summary

The purpose of this study is to describe the impact of the iFuse Bedrock technique to decrease post-operative pains in patients who underwent multilevel posterior lumbosacral fusion.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 11, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

June 10, 2022

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

November 8, 2024

Status Verified

November 1, 2024

Enrollment Period

3.8 years

First QC Date

February 21, 2022

Last Update Submit

November 6, 2024

Conditions

Keywords

Sacroiliac joint painSacroiliac joint fusionBedrock techniqueOpen posterior lumbosacral fusionSpine deformties

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in self-reported Oswestry Disability Index (ODI) at 12 months

    A decrease of 16 points in the ODI score at 12 months compared to the preoperative score is expected in order to demonstrate a 30% effecacy of the iFuse Bedrock technique in reducing postoperative pain.

    12 months

Secondary Outcomes (14)

  • Change from baseline in sacroiliac joint pain provocation tests.

    During 12 months

  • Assessment of the Oswestry Disability Index

    3 and 6 months

  • Improvement of back and leg pains at 3, 6 and 12 months compared to preoperative scores

    3, 6 and 12 months

  • Change in Patient's quality of life

    3, 6 and 12 months

  • Proportion of subjects with postoperative SIJ fusion failure

    12 months

  • +9 more secondary outcomes

Study Arms (1)

iFuse Bedrock technique

Multilevel lumbar fusion procedure with additional sacroiliac joint stabilization using the iFuse-3D system

Device: iFuse Bedrock technique

Interventions

Lumbosacral arthrodesis on 2 or more spinal segments (including at least L4, L5 and S1 vertebrae) associated with a sacroiliac fusion procedure according to the Bedrock technique using the iFuse 3D system and iliac fixation.

iFuse Bedrock technique

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All participants enrolled in the study are adult subjects who underwent an open posterior lumbosacral fusion procedure with additional sacroiliac joint fusion according to the iFuse Bedrock technique (insertion of the iFUSE-3D implant). Lumbosacral fusion involved at least the following vertebrae : L4, L5 and S1.

You may qualify if:

  • Subject scheduled for open posterior lumbosacral arthrodesis (including at least the following three vertebrae: L4, L5 and S1) associated with a sacroiliac fusion procedure and iliac fixation (thoracolumbar fusion procedures extended to sacrum are eligible in the study);
  • Insertion of at least 1 iFuse-3D implant according to the iFuse Bedrock technique (uni- and bilateral insertion are eligible);
  • Subject who preoperatively responded positively to pain provocation tests for SIJ dysfunction with or without a positive SIJ infiltration test;
  • Patient with a degenerative sacroiliac joint disease requested a fusion procedure;

You may not qualify if:

  • Major osteoporosis (DEXA scan \> 3);
  • Any previous history of sacroiliac joint fusion or any surgical procedure involving a S2-iliac fusion;
  • Subjects requested a SIJ fusion without the iFuse-3D device or iFuse-3D not inserted according to the manufacturer instruction (Bedrock technique);
  • Subjects with a medical or surgical contraindication preventing the intervention from being performed or potentially interfering in the interpretation of the data collected (neurologic condition, local or systemic infection, any known allergy to surgical implants, psychiatric diseases, ...);
  • Currently pregnant or planning pregnancy;
  • Prisoner or a ward of the state;
  • Subject no willing to participate in the study;
  • Subject not affiliated to a social security insurance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Polyclinique Bordeaux Nord Aquitaine

Bordeaux, 33300, France

RECRUITING

Hôpitaux Universitaires de Marseille

Marseille, 13005, France

RECRUITING

MeSH Terms

Conditions

Sacroiliitis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal Diseases

Study Officials

  • Jean Charles Le Huec, M.D., PhD

    VERTEBRA Institute, Polyclinique Bordeaux Nord Aquitaine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2022

First Posted

March 11, 2022

Study Start

June 10, 2022

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

November 8, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations